Navigation Links
Isis Highlights Robust Drug Portfolio for Diabetes and Obesity at ADA Conference
Date:6/10/2008

iabetic animals, and reduced fed and fasted blood glucose levels,

while also ameliorating diabetic complications, including slowing

progression of cataract formation.

-- Lowered SGLT2 mRNA levels in the kidney by approximately 80% in all

species tested, with doses as low as 1-2 mg/kg/week with no effect on

SGLT1, a related protein, where levels of activity is desirable.

-- Showed no changes in urinary or plasma markers of renal function and

no harmful effects such as low blood glucose.

"In preclinical models, lowering levels of SGLT2 in the kidney by an antisense drug demonstrated very potent reduction in blood glucose that supports the possibility of an infrequent monthly injectable dosing or, potentially, a cost effective oral administration. Furthermore, our SGLT2 inhibitor complements our diabetes drugs in development, and offers a unique and complementary approach to treat diabetes," said Sanjay Bhanot, M.D., Ph.D., Vice President of Metabolic Diseases Research & Development of Isis Pharmaceuticals. "We are moving ISIS 388626, our human antisense SGLT2 inhibitor, toward human clinical proof-of-concept as rapidly as possible, and we look forward to continuing to populate our metabolic disease pipeline with exciting drugs arising from our research program."

As part of Isis' metabolic disease franchise, data from eight additional research programs conducted by Isis and its collaborators were presented at ADA this year, evaluating the effects of antisense drugs against eight promising new targets in a variety of species and models, including diabetic animals. Results of the studies showed that antisense technology reduced mRNA target levels in specific tissues and provided early signs of therapeutic benefit in various models of disease, offering robust and sustained effects for the treatment of obesity, type 2 diabetes and lipid metabolism disorders. Complete abstracts for these presentat
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Uroplasty Highlights Clinical Results From a Study of the Urgent(R) PC Neuromodulation System
2. Memory Pharmaceuticals Highlights Progress with Key Programs at its R&D Day
3. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting
4. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting
5. Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights
6. Sarasotas Roskamp Institute Highlights Positive Japanese Data that Validates its Ongoing Alzheimers Disease Research
7. Research Highlights Potential Benefits of Telemedicine in Treating Eye Disease
8. Synvista Therapeutics Highlights New Data Demonstrating the Clinical Benefit of Vitamin E Therapy in Patients Identified on the Basis of Haptoglobin Phenotype Testing
9. Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting
10. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
11. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... Aug. 20, 2014 Research and Markets  has ... Pralmorelin" report to their offering. Global ... data on Pralmorelin globally and regionally ( Europe ... , Latin America etc.). It ... This report focuses on three primary areas; manufacture methods ...
(Date:8/20/2014)... 2014   Ventana Medical Systems, Inc.  (Ventana), ... that its VENTANA System for Primary Diagnosis 1 ... Union for routine pathology, including primary diagnosis with ... Virtuoso software coupled with either the VENTANA iScan ... provides automated digital slide creation, case management and ...
(Date:8/20/2014)... ANN ARBOR, Mich. and ... a non-profit corporation established to bring cutting-edge next-generation ... trials to cancer patients, today announced a collaboration ... molecular capabilities to characterize patient tissue samples from ... be sensitive or resistant to TESARO,s TSR-011.  This may ...
Breaking Medicine Technology:Global Market Report of Pralmorelin 2Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 2Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 3Paradigm Announces Molecular Profiling Collaboration with TESARO, Inc. 2
... Corp., formerly known as InstaCare Corp., (OTCQB: ISCRD), a ... the chronically ill, a leading fulfillment provider of direct ... revolutionary cell phone centric e -health products and ... Dividend will be Ex-Dividend to all shareholders of record ...
... ENDP ) today announced that David Holveck, president ... Morgan 30th Annual Healthcare Conference on Monday, January 9, 2012 ... the Westin St. Francis in San Francisco, Calif. ... be available on the company,s website at http://www.endo.com/ .  ...
Cached Medicine Technology:Decision Diagnostic Corp. Clarifies 10% Stock Dividend, Announces Patent Enforcement Strategy 2
(Date:8/21/2014)... HIPAA Secure Now! rolled out its EHR (electronic ... vendors to now offer their customers a HIPAA security ... , HIPAA Secure Now! provides risk analysis services, ... U.S. The company assesses the risks of storing and ... and device used by the practice. , HIPAA ...
(Date:8/21/2014)... 21, 2014 Inc. magazine ranked Centurion ... 500|5000, an exclusive ranking of the nation's fastest-growing private ... the most important segment of the economy—America’s independent entrepreneurs. ... LinkedIn, Zillow, and many other well-known names gained early ... is proud to have been named to the Inc. ...
(Date:8/21/2014)... August 21, 2014 The rising numbers of ... Boynton Beach, FL. For many years, countless lives have been ... in the community a new helpline was established to provide ... Florida who are seeking to overcome their youth substance ... Boynton Beach helpline at (561) 257-4053, parents and their teens ...
(Date:8/21/2014)... August 21, 2014 Drake University’s Phi ... $10,000 to support ovarian cancer research, according to Billy ... is also the kicker for the Cleveland Browns, says ... was matched by Colleen’s Dream Foundation and will fund ... Assistant Professor in the Division of Gynecologic Oncology at ...
(Date:8/20/2014)... August 21, 2014 Top 10 ... web hosting companies and announced Bluehost ( http://www.bluehost.com/track/seohosts ... hosting companies that provide high quality PHP hosting ... Top 10 Best SEO Hosting are unbiased and ... the best information possible. During the recent years, ...
Breaking Medicine News(10 mins):Health News:HIPAA Secure Now! Ramps up EHR Partner Program, Helps Healthcare Providers Achieve Meaningful Use under Revised CMS Deadlines 2Health News:Centurion Service Group Named to Inc. Magazine's List of the Nation's Fastest-Growing Private Companies 2Health News:Centurion Service Group Named to Inc. Magazine's List of the Nation's Fastest-Growing Private Companies 3Health News:Centurion Service Group Named to Inc. Magazine's List of the Nation's Fastest-Growing Private Companies 4Health News:Troubled Teens in Boynton Beach, FL Turn to Helpline for Valuable Assistance 2Health News:Drake University’s Phi Gamma Delta (FIJI) and Colleen’s Dream Foundation Donate $10,000 to the University of Iowa’s Holden Cancer Center to Fight Ovarian Cancer 2Health News:Drake University’s Phi Gamma Delta (FIJI) and Colleen’s Dream Foundation Donate $10,000 to the University of Iowa’s Holden Cancer Center to Fight Ovarian Cancer 3Health News:New Reviews Of Cheap PHP Hosting Companies Unveiled By Top 10 Best SEO Hosting 2
... Bethesda, MD (November 1, 2007) Diabetes is a very ... the U.S. and it is estimated an additional 54 million ... blood glucose levels are higher than normal but not high ... is important to determine whether glucose and insulin levels are ...
... Nov. 1 NuVasive, Inc. (Nasdaq:,NUVA), a medical device ... for the spine, announced today,that Alex Lukianov, Chairman and ... Investor Conference 2007 at the San Diego Marriott,Del Mar ... 2007 at 9:30 a.m.,PT. A live Web cast ...
... See their First Birthday, LOS ANGELES, Nov. 1 On ... all babies -- those born healthy,those who need help to thrive ... infants die before their first birthday each year -- more,than 5,000 ... Vicente Perez, Jr. is just one of those., He was ...
... Reps. Shelley Moore Capito and Tom Allen Express ... Nov. 1 Warning that cuts to,seniors, Medicare ... quality of,care and quality of life of America,s ... care, a broad array of clinician and,caregiver groups ...
... Mayo Clinic study of a drug that has shown promise ... drug may also be effective in treating breast cancer, in ... was done in mouse models, is featured on the cover ... National Cancer Institute reports that of 240,510 breast cancer diagnoses ...
... slowly to save their lives can be an invasive ... to the November issue of Journal of Clinical Nursing. ... Dublin, has called for clinical and legal guidelines to ... and highlighted the need for better communication about do ...
Cached Medicine News:Health News:Increased glucose level is a strong risk factor for colorectal cancer 2Health News:Increased glucose level is a strong risk factor for colorectal cancer 3Health News:NuVasive to Present at BIOCOM Investor Conference 2007 2Health News:NuVasive to Present at BIOCOM Investor Conference 2007 3Health News:March of Dimes Honors Babies on 'El Dia de Todos los Santos' 2Health News:Coalition of Caregivers Warns Congress of Danger to Oldest U.S. Seniors if Medicare Slashed 2Health News:Coalition of Caregivers Warns Congress of Danger to Oldest U.S. Seniors if Medicare Slashed 3Health News:Coalition of Caregivers Warns Congress of Danger to Oldest U.S. Seniors if Medicare Slashed 4Health News:Mayo Clinic study shows drug could effectively treat, prevent the spread of breast cancer 2Health News:Mayo Clinic study shows drug could effectively treat, prevent the spread of breast cancer 3Health News:Token resuscitation attempts on hopelessly ill patients prolong suffering 2Health News:Token resuscitation attempts on hopelessly ill patients prolong suffering 3
The Sutura family of products is designed to allow interventionalists to perform vessel closure from 6F up to 24F. It's elegant design allows one-handed use through sheath, routinely eliminating need...
The Closer vascular closure device is a suture mediated closure system. It has a sheath-like profile and easy positioning. It has an innovative design which involves the needles outside the artery an...
Spyglass angiography catheters, combined with St. Jude Medical hemostasis introducers and GuideRight guidewires, offer a safe and effective diagnostic angiography system....
Jography angiographic catheter has a new material combination, a patented angled weld, a flat wire braid design with a XXL lumen. It also has an atraumatic soft tip....
Medicine Products: